SCHEMBL18106902

SCHEMBL18106902

N#Cc1ccc2[nH]c(NC(=O)O)nc2c1.c1ccc(C2CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
IRAK4 Q9NWZ3 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.44
FASN P49327 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.42
LPAR2 Q9HBW0 2/20 0.42
MAPK10 P53779 3/20 0.41
ABL1 P00519 1/20 0.41
PKM P14618 1/20 0.41
MAOB P27338 1/20 0.41
ADORA2A P29274 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CSNK1D P48730 1/20 0.41
GSK3B P49841 1/20 0.41
CSNK1G2 P78368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18106901 0.91 PIN1 (0.51) NPC1RAB9AIRAK4SMN1; SMN2FASN
SCHEMBL18106906 0.83 SMN1; SMN2 (0.63) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL18106894 0.82 NPC1 (0.51) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL18106893 0.81 TUBB4A (0.51) NPC1RAB9AIRAK4SMN1; SMN2POLB
SCHEMBL18106911 0.81 ABL1 (0.46) NPC1RAB9AIRAK4FASNLPAR2
SCHEMBL18106889 0.81 RAB9A (0.50) NPC1RAB9ASMN1; SMN2CYP1A2LPAR2
SCHEMBL15944962 0.81 LPAR2 (0.64) NPC1RAB9AIRAK4SMN1; SMN2POLB
SCHEMBL18106904 0.78 LPAR2 (0.48) NPC1RAB9AIRAK4SMN1; SMN2POLB
SCHEMBL18106898 0.77 LPAR2 (0.66) NPC1RAB9AIRAK4SMN1; SMN2POLB
SCHEMBL18106895 0.76 LPAR2 (0.67) NPC1RAB9ASMN1; SMN2POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742029-B1 N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS MERCK PATENT GMBH (DE) 2016-10-05 EP claimed